VSD anaphylaxis study
Ended Awarded Last action
- Contract number
- HHSD2002012535810004
- Awardee
-
Kaiser Foundation Hospitals UEI P1RTMASB37B5
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Obligated
- $150,337
Award facts
- Opportunity
-
- 2012N14282 Solicitation number
- Contract value 95% obligated
-
- $150,337.43 Current, with exercised options
- $158,855.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 9 offers Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Oakland, CA 94612, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$8,518 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Original award | $158,855 |
About this award
The Centers for Disease Control and Prevention (CDC) Pittsburgh awarded a delivery order valued at $158,855 to Kaiser Foundation Hospitals (doing business as Kaiser Permanente) on September 28, 2012, for the VSD Anaphylaxis Study. This delivery order was issued under the Vaccine Safety Datalink (VSD) Project master IDIQ and was performed in Oakland, California. The contract operated on a cost-no-fee basis with an ultimate completion date of September 30, 2014, and was not designated as a set-aside contract.
Kaiser Foundation Hospitals' research division, the Kaiser Foundation Research Institute, conducted this anaphylaxis safety research leveraging its integrated healthcare system and extensive patient data resources. The VSD Project, through which this delivery order was awarded, is a long-standing CDC collaboration with major healthcare organizations designed to monitor vaccine safety using electronic health records and medical claims data. This particular anaphylaxis study aligns with CDC's core vaccine safety surveillance mission and benefits from Kaiser Permanente's established capabilities in epidemiological research, vaccine safety monitoring, and clinical data analysis across its large, diverse patient population.
Quick answers
Who was awarded contract HHSD2002012535810004?
HHSD2002012535810004 was awarded to Kaiser Foundation Hospitals by CDC Pittsburgh (Centers for Disease Control and Prevention) on September 28, 2012.
How much is contract HHSD2002012535810004 worth?
The government has obligated $150,337 on HHSD2002012535810004. Its potential value, with all options, is $158,855.
Is contract HHSD2002012535810004 an order under another contract?
Yes. HHSD2002012535810004 is a delivery order under HHSD200201253581I, an indefinite delivery contract, on Vaccine Safety Datalink Project.
Was contract HHSD2002012535810004 competed?
The extent of competition for HHSD2002012535810004 was full and open competition. The government received 9 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award